Abstract

Bisphosphonates (BP) are the most commonly used medications for the treatment of osteoporosis. Of them, the most frequently prescribed worldwide is alendronate. Of the various compounds available, those that are ingested are usually indicated, but they are also available for intravenous use at different intervals, depending on their potency [1].